News

Yet “lost albums” are embedded in music industry lore. Some were literally lost. Some remained unfinished or unreleased because of tragedy, shortsighted executives or creators who were perfectionist — ...
The once-monthly drug is still under study but could provide added convenience and another option for patients.
A new drug from California-based pharma company Amgen, which has concluded a phase II trial, shows promise as a powerful ...
What if we told you that scientists are currently testing a new weight-loss drug that’s similar to Ozempic but sans the scary ...
Most patients with diabetes suffer from impaired endothelial function and neointimal thickening, which contribute to arterial atherosclerosis and increase the frequency of adverse cardiovascular ...
The field of drug development is a time-consuming and costly process, with the development of individual pharmaceutical products estimated to take between 11 and 14 years and cost between 161-1,800 ...
Remarkably, both polymer–drug conjugates exhibited no cytotoxicity, in stark contrast to plain PAMAM dendrimers. With sufficiently long vitreous half-lives, both synthesized polymer–ARB conjugates ...
Smart technologies, such as digital and laser printing, incorporated into manufacturing equipment are helping manufacturers align with sustainability goals, according to Sheikh Akbar Ali, general ...
Iluzanebart’s failure is another ding for a TREM2 space that has already seen a recent high-profile failure. Last November, Alector’s TREM2 antibody failed its own Phase II study for Alzheimer’s ...
Entrepreneurs are looking at straws as a way to detect when a drink has been tampered with. Here & Now‘s Robin Young speaks with Neve Palmeri, a sophomore at Providence College who recently won the ...
A reusable drinking straw, called Smart Sip, can detect the chemicals of a drug. How the Smart Sip detects date rape drugs | WJCT News 89.9 Search Query Show Search ...
Merck MRK announced encouraging data from the dose confirmation portion of the phase II/III waveLINE-003 study evaluating its first-in-class antibody drug conjugate (ADC), zilovertamab vedotin ...